
Latest News in Parkinson Disease: COVID-19 Neurological Complications, Technological Innovations, and More
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
An overview of the latest news in
COVID-19 Neurological Complications Linked With Mortality, Longer Hospital Stay
Patients with neurological conditions such as PD, Alzheimer disease (AD), and all-cause dementia have been shown in
Individuals who developed neurological complications of COVID-19 were shown to be of older age and stay in hospitals more than 2-fold longer, on average, compared with regular patients, and they were also associated with more frequent discharge to a subacute rehabilitation facility.
Notably, research
Integrating Novel Technology in Management of Advanced PD
In a Peer Exchange series by
Addressing approaches to incorporate technology in the management of PD, panelists mentioned 2 ways to do so: the use of wearable technology and the use of smart homes. Smart homes, which function by having devices planted in the house to track the motor behavior of patients, were regarded as an experimental approach still currently under investigation.
Furthermore, the use of deep-brain stimulation and in-brain sensing was noted, which may open possibilities for adaptive devices that would alter or administer doses based on a patient’s dopamine levels.
Cause for Most Common Form of PD Identified
In a recent study by researchers from the University of Copenhagen, the most common form of PD, sporadic PD, was found to be caused by the blockage of a pathway that regulates the mitochondria.
Published in
Following their findings, researchers
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.